You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

2026 › June › 09

FTSE

47 days ago

GSK to buy US cancer treatment firm Nuvalent for $10.6bn ⊖⊖

found 2026 › Jun › 09 (Tue) @ 08:03 UTC

a story from The Guardian ⚠️ › International

British drugmaker’s new chief executive Luke Miels announces one of its biggest deals

Business live – latest updates

GSK’s new boss Luke Miels has struck one of the British drugmaker’s biggest deals, a…

48 days ago

Fresh blow to City as Tate & Lyle is swallowed by US rival Ingredion in £2.7bn deal ⊕

found 2026 › Jun › 09 (Tue) @ 01:27 UTC

a story from The Daily Mail 💩 › The Daily Mail

Tate & Lyle, which was an original member of the FT 30 index in 1935 and FTSE 100 in 1984, accepted a 615p per share offer from US rival Ingredion.

page 1 of 1